The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 17, 2022
Filed:
Mar. 17, 2020
Applicants:
Incyte Corporation, Wilmington, DE (US);
Incyte Holdings Corporation, Wilmington, DE (US);
Inventors:
James D. Rodgers, Jupiter, FL (US);
Stacey Shepard, Wilmington, DE (US);
Assignees:
Incyte Holdings Corporation, Wilmington, DE (US);
Incyte Cororation, Wilmington, DE (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61P 29/00 (2006.01); A61P 35/04 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 417/04 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01); A61P 17/04 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); C07B 59/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 9/20 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61P 17/04 (2018.01); A61P 29/00 (2018.01); A61P 35/04 (2018.01); C07B 59/002 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07B 2200/05 (2013.01);
Abstract
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.